AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Learning When To Hold, When To Fold.(THE SMART INVESTOR)(IBD INVESTOR PROFILE)

Investor's Business Daily

| May 02, 2002 | COPYRIGHT 2002 Investor's Business Daily, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

Byline: DAVID SAITO-CHUNG

If you have a hard time holding on to a good stock for a long while, meet Somabhai Patel. He's held shares of Amgen since 1986.

And smartly so. The stock, up 11,000% from where he bought it, taught him one of the most important lessons in great investing: Buy and hold winners only, not losers.

"I learned to make sure you buy a stock when it is moving up, and to buy in volume," said the retired manager of software systems at a regional bank in California.

On June 5, 1986, Patel took a tip from a broker and planted his first position at 26 a share in the young biotech. That year, Amgen had $31 million in sales and was barely profitable. Patel consulted his son, who has a doctorate in immunology. His thumbs-up gave Patel more confidence in the stock.

He sure needed it. Soon after Patel bought the stock, it dropped hard, going from about 29 to a low of 13.25 in three months. But Amgen recovered. In January 1987, Patel added shares at about 23. This time, it shot out of a good base and rose as high as 44.75 in March that year.

But the stock corrected sharply again in the summer. Then it dived all the way to 16 just days after "Black Monday" on Oct. 19, 1987. From that point, it took nearly two years before Amgen hit a new high.

Related articles from newspapers, magazines, journals, and more
Hatching innovation: duo seeks to tap ex-Amgen workers for Agoura Hills startup...
Magazine article from: Los Angeles Business Journal Proctor, Charles August 25, 2008 700+ words
...entrepreneurs attended. Among them was Vikram Patel, a biotech consultant in Camarillo. Patel was a director of research at Amgen until he was laid off last summer...the biotech giant For over a year, Patel has nursed the idea of starting a biotech...
Connetics Taps New M&A Pro.(appoints Sunil Patel)
Newspaper article from: Mergers & Acquisitions Report Catton, Grant May 22, 2006 700+ words
...company announced it hired Sunil Patel to the position of VP of corporate...notable about the hire is that Patel comes directly from $2 billion...80 billion pharmaceutical giant Amgen Inc. At Abgenix, Patel was senior director of strategic...
Amgen and Takeda Announce Exclusive Collaboration in Japan on up to 13 Amgen...
Press release article from: Business Wire February 4, 2008 700+ words
Amgen to Receive $200 Million Upfront Payment...for Motesanib Diphosphate, which Provides Amgen with an Additional $100 Million Upfront...OAKS, Calif. & OSAKA, Japan -- Amgen (NASDAQ:AMGN) and Takeda Pharmaceutical...
Amgen to Acquire Tularik for $1.3 Billion.
Press release article from: Business Wire March 29, 2004 700+ words
...BUSINESS WIRE)--March 29, 2004--Amgen Inc. (Nasdaq:AMGN) and Tularik Inc...Adds Five Clinical Development Candidates to Amgen's Pipeline; -- Further Strengthens Amgen's Research Capabilities and Accelerates Planned...
Amgen Opens The Secret Curtain.
News wire article from: The America's Intelligence Wire March 22, 2004 700+ words
(From BusinessWeek) Amgen Inc. is used to its perch at the pinnacle...competitors. Yet when it comes to innovation, Amgen is no highflier. Its best-selling drug...1989. So when Roger Perlmutter joined Amgen as head of research three years ago...
AMGEN COMPLETES ACQUISITION OF ABGENIX.
News wire article from: AsiaPulse News April 4, 2006 700+ words
...BUSINESS WIRE)--April 3, 2006--Amgen (NASDAQ: AMGN), the world's largest...Abgenix stockholders overwhelmingly approved Amgen's acquisition of the company during a...chairman and chief executive officer of Amgen. "We welcome the Abgenix staff into our...
Amgen's $16 Billion Deal Sets Up Takeover of Seattle-Based Immunex.
Newspaper article from: Knight Ridder/Tribune Business News December 17, 2001 700+ words
...Ridder/Tribune Business News Dec. 17--Amgen, the world's largest biotech company...rival the world's biggest drug makers. Amgen plans to acquire Immunex for slightly less...familiar with the deal. The boards of Amgen, Immunex and American Home Products...
Amgen Completes Acquisition of Abgenix; Acquisition Provides Amgen with Full...
Press release article from: Business Wire April 3, 2006 700+ words
THOUSAND OAKS, Calif. -- Amgen (NASDAQ: AMGN), the world's largest...stockholders overwhelmingly approved Amgen's acquisition of the company during...chairman and chief executive officer of Amgen. "We welcome the Abgenix staff into...
Amgen to Acquire Abgenix for $22.50 Per Share.
Press release article from: PR Newswire December 14, 2005 700+ words
Provides Amgen With Full Ownership of Panitumumab and Eliminates...Dec. 14 /PRNewswire-FirstCall/ -- Amgen , the world's largest biotechnology company...definitive merger agreement under which Amgen will acquire Abgenix for approximately...
Amgen Posts Medical Education and Foundation Grants and Donations as Part of...
Press release article from: Business Wire May 22, 2008 700+ words
THOUSAND OAKS, Calif. -- Amgen (NASDAQ: AMGN) today posted to the company's Web site grants and donations made by the Amgen Medical Education department (AmgenMED) and the Amgen Foundation. The posting is the latest element...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA